Your search returned 1590 results.

Results
	1581.	Inhibition of MCL-1 in breast cancer cells promotes cell death in vitro and in vivo. [electronic resource] by Mitchell, Clint Yacoub, Adly Hossein, Hamed Martin, Aditi Pandya Bareford, M Danielle Eulitt, Patrick Yang, Chen Nephew, Kenneth P Dent, Paul Producer: 20110706 In: Cancer biology & therapy vol. 10 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	1582.	Radiologic and Genomic Evolution of Individual Metastases during HER2 Blockade in Colorectal Cancer. [electronic resource] by Siravegna, Giulia Lazzari, Luca Crisafulli, Giovanni Sartore-Bianchi, Andrea Mussolin, Benedetta Cassingena, Andrea Martino, Cosimo Lanman, Richard B Nagy, Rebecca J Fairclough, Stephen Rospo, Giuseppe Corti, Giorgio Bartolini, Alice Arcella, Pamela Montone, Monica Lodi, Francesca Lorenzato, Annalisa Vanzati, Alice Valtorta, Emanuele Cappello, Giovanni Bertotti, Andrea Lonardi, Sara Zagonel, Vittorina Leone, Francesco Russo, Mariangela Balsamo, Antonella Truini, Mauro Di Nicolantonio, Federica Amatu, Alessio Bonazzina, Erica Ghezzi, Silvia Regge, Daniele Vanzulli, Angelo Trusolino, Livio Siena, Salvatore Marsoni, Silvia Bardelli, Alberto Producer: 20190409 In: Cancer cell vol. 34 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	1583.	OSU-03012 interacts with lapatinib to kill brain cancer cells. [electronic resource] by Booth, Laurence Cruickshanks, Nichola Ridder, Thomas Chen, Ching-Shih Grant, Steven Dent, Paul Producer: 20130626 In: Cancer biology & therapy vol. 13 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	1584.	Histone deacetylase inhibitors restore toxic BH3 domain protein expression in anoikis-resistant mammary and brain cancer stem cells, thereby enhancing the response to anti-ERBB1/ERBB2 therapy. [electronic resource] by Cruickshanks, Nichola Hamed, Hossein A Booth, Laurence Tavallai, Seyedmehrad Syed, Jahangir Sajithlal, Gangadharan B Grant, Steven Poklepovic, Andrew Dent, Paul Producer: 20140610 In: Cancer biology & therapy vol. 14 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	1585.	Autophagy-related gene 12 (ATG12) is a novel determinant of primary resistance to HER2-targeted therapies: utility of transcriptome analysis of the autophagy interactome to guide breast cancer treatment. [electronic resource] by Cufí, Sílvia Vazquez-Martin, Alejandro Oliveras-Ferraros, Cristina Corominas-Faja, Bruna Urruticoechea, Ander Martin-Castillo, Begoña Menendez, Javier A Producer: 20130812 In: Oncotarget vol. 3 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	1586.	Sorafenib/regorafenib and lapatinib interact to kill CNS tumor cells. [electronic resource] by Hamed, Hossein A Tavallai, Seyedmehrad Grant, Steven Poklepovic, Andrew Dent, Paul Producer: 20150109 In: Journal of cellular physiology vol. 230 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	1587.	Combined targeting of TGF-β, EGFR and HER2 suppresses lymphangiogenesis and metastasis in a pancreatic cancer model. [electronic resource] by Gore, Jesse Imasuen-Williams, Imade E Conteh, Abass M Craven, Kelly E Cheng, Monica Korc, Murray Producer: 20170726 In: Cancer letters vol. 379 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	1588.	HER2-positive breast cancer cells resistant to trastuzumab and lapatinib lose reliance upon HER2 and are sensitive to the multitargeted kinase inhibitor sorafenib. [electronic resource] by Valabrega, Giorgio Capellero, Sonia Cavalloni, Giuliana Zaccarello, Gianluca Petrelli, Annalisa Migliardi, Giorgia Milani, Andrea Peraldo-Neia, Caterina Gammaitoni, Loretta Sapino, Anna Pecchioni, Carla Moggio, Aldo Giordano, Silvia Aglietta, Massimo Montemurro, Filippo Producer: 20120914 In: Breast cancer research and treatment vol. 130 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	1589.	AKT inhibition relieves feedback suppression of receptor tyrosine kinase expression and activity. [electronic resource] by Chandarlapaty, Sarat Sawai, Ayana Scaltriti, Maurizio Rodrik-Outmezguine, Vanessa Grbovic-Huezo, Olivera Serra, Violeta Majumder, Pradip K Baselga, Jose Rosen, Neal Producer: 20110314 In: Cancer cell vol. 19 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	1590.	Genomic and genetic characterization of cholangiocarcinoma identifies therapeutic targets for tyrosine kinase inhibitors. [electronic resource] by Andersen, Jesper B Spee, Bart Blechacz, Boris R Avital, Itzhak Komuta, Mina Barbour, Andrew Conner, Elizabeth A Gillen, Matthew C Roskams, Tania Roberts, Lewis R Factor, Valentina M Thorgeirsson, Snorri S Producer: 20120531 In: Gastroenterology vol. 142 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)

First
Previous
71
72
73
74
75
76
77
78
79
80